247 related articles for article (PubMed ID: 38510241)
1. Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approach.
Stemmer E; Zahavi T; Kellerman M; Sinberger LA; Shrem G; Salmon-Divon M
Front Immunol; 2024; 15():1353402. PubMed ID: 38510241
[TBL] [Abstract][Full Text] [Related]
2. Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases.
Heydari R; Fayazzadeh S; Shahrokh S; Shekari F; Farsad F; Meyfour A
Inflamm Bowel Dis; 2024 May; 30(5):795-807. PubMed ID: 37855715
[TBL] [Abstract][Full Text] [Related]
3. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
[TBL] [Abstract][Full Text] [Related]
4. Gene Identification in Inflammatory Bowel Disease via a Machine Learning Approach.
Alfonso Perez G; Castillo R
Medicina (Kaunas); 2023 Jun; 59(7):. PubMed ID: 37512030
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.
Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
[TBL] [Abstract][Full Text] [Related]
7. Associations between Cellular Energy and Pediatric Inflammatory Bowel Disease Patient Response to Treatment.
Starr AE; Deeke SA; Ning Z; de Nanassy J; Singleton R; Benchimol EI; Mack DR; Stintzi A; Figeys D
J Proteome Res; 2021 Sep; 20(9):4393-4404. PubMed ID: 34424714
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNAs as pathophysiological regulators, therapeutic targets and novel extracellular vesicle biomarkers for the diagnosis of inflammatory bowel disease.
Heydari R; Karimi P; Meyfour A
Biomed Pharmacother; 2024 Jul; 176():116868. PubMed ID: 38850647
[TBL] [Abstract][Full Text] [Related]
9. Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
Alfaifi J; Germain A; Heba AC; Arnone D; Gailly L; Ndiaye NC; Viennois E; Caron B; Peyrin-Biroulet L; Dreumont N
Inflamm Bowel Dis; 2023 Jun; 29(6):986-999. PubMed ID: 36545755
[TBL] [Abstract][Full Text] [Related]
10. Proteomic insights on the metabolism in inflammatory bowel disease.
Pisani LF; Moriggi M; Gelfi C; Vecchi M; Pastorelli L
World J Gastroenterol; 2020 Feb; 26(7):696-705. PubMed ID: 32116417
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?
de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020
[TBL] [Abstract][Full Text] [Related]
12. Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn's Disease and Ulcerative Colitis.
Dobre M; Milanesi E; Mănuc TE; Arsene DE; Ţieranu CG; Maj C; Becheanu G; Mănuc M
J Immunol Res; 2018; 2018():9208274. PubMed ID: 30417021
[TBL] [Abstract][Full Text] [Related]
13. Serum matrix metalloproteinase-9 concentration as a marker of disease activity in patients with inflammatory bowel disease.
Shamseya AM; Hussein WM; Elnely DA; Adel F; Header DA
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e803-e809. PubMed ID: 34678857
[TBL] [Abstract][Full Text] [Related]
14. Exploring inflammatory bowel disease therapy targets through druggability genes: a Mendelian randomization study.
Zhu S; Lin Y; Ding Z
Front Immunol; 2024; 15():1352712. PubMed ID: 38707907
[TBL] [Abstract][Full Text] [Related]
15. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
16. Screening of hub inflammatory bowel disease biomarkers and identification of immune-related functions based on basement membrane genes.
Lin P; Hua J; Teng Z; Lin C; Liu S; He R; Chen H; Yao H; Ye J; Zhu G
Eur J Med Res; 2023 Jul; 28(1):247. PubMed ID: 37481583
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.
Bennike T; Birkelund S; Stensballe A; Andersen V
World J Gastroenterol; 2014 Mar; 20(12):3231-44. PubMed ID: 24696607
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic analysis of potential candidates for therapy of inflammatory bowel disease.
Li XL; Zhou CY; Sun Y; Su ZY; Wang X; N Jia E; Zhang Q; Jiang XF; Qi WQ; Xu Y
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4275-84. PubMed ID: 26636514
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
20. Short noncoding RNAs as predictive biomarkers for the development from inflammatory bowel disease unclassified to Crohn's disease or ulcerative colitis.
James JP; Riis LB; Søkilde R; Malham M; Høgdall E; Langholz E; Nielsen BS
PLoS One; 2024; 19(2):e0297353. PubMed ID: 38408066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
